Recent Blog Posts

View Post: Clinical Trial Of RG7128 For The Treatment Of Hepatitis C
Procto-Med
24 Nov 2009 by DoctorFrog   ...
View Blog: http://www.procto-med.com/

---

View Post: Eurosurveillance - View Article
25 Nov 2009
Transmission of viral hepatitis is a problem not only in low-income countries, but also in high-income ones where viral hepatitis is a frequently occurring infection among men who have sex with men (MSM). ... HBV carriers treatment includes interferon and nucleoside analogues, while pegylated-interferon, in combination with ribavirin, is available for chronic HCV [1, 2]. For both viruses, but especially chronic HBV, treatment does not always result in viral eradication. ...
View Blog: Eurosurveillance latest updates - http://www.eurosurveillance.org/

---

View Post: PipelineReview.com - Biotech News & Online Store - Pharmasset ...
22 Nov 2009 by Mario Papayannis  
S, OTCQX: RHHBY), will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b trial of RG7128, a first-in-class nucleoside analog polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection. ... Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the ...
View Blog: PipelineReview.com News Channe () - http://www.pipelinereview.com/

---

View Post: Boost for Biota Research Productivity: Drug Discovery Head Wins ...
28 Feb 2007 by noemail@advance.org  
Biota Holdings Limited (ASX:BTA), a world-leading anti-viral drug development company, is set to improve its research productivity measurement tools, thanks to this new initiative by Merck Sharp & Dohme and Advance. ... Boehringer Ingelheim International GmbH to develop and commercialise Biota's novel nucleoside analogues for the treatment of hepatitis C virus;. MedImmune Inc to develop Biota's lead compounds aimed at RSV (respiratory syncytial virus); ...
View Blog: Advance - http://www.advance.org/en/rss/

---

View Post: Proactive Investors (AU) - Biota Holdings acquires Boston-based ...
11 Nov 2009
Subsequent Biota research breakthroughs have included novel nucleoside analogues designed to treat hepatitis C virus (HCV) infections, licensed to Boehringer Ingelheim, and a series of candidate drugs aimed at treatment of respiratory ...
View Blog: Proactiveinvestors Australia RSS feed - http://www.proactiveinvestors.com.au/

---

View Post: Hepatitis B, Chronic Clinical Trial: Lamivudine Therapy in ...
11 Nov 2009
They will be eligible if their liver tests are normal and their viral load is undetectable. Patients will be switched to lamivudine treatment to assess whether lamivudine can maintain adequate suppression of the hepatitis B virus... Date First Received: November 12, ... Patients with chronic hepatitis B treated with entecavir for 6 months or more; Normal ALT; Undetectable HBV DNA by Roche Taqman PCR Assay; No other previous therapy with nucleoside/nucleotide analogues ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Pharmasset Announces The Continued Enrollment Of The Phase 2b ...
24 Nov 2009 by Correspondent  
S, OTCQX: RHHBY), will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b trial of RG7128, a first-in-class nucleoside analog polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) ...
View Blog: Davabazaar in India - beta - http://www.davabazar.com/cms/

---

View Post: (BLOG) - Lifestyle in Judo: FATAL FLAW.(AIDS virus research).
20 hours ago by Blog  
Their biotech company, Koronis Pharmaceuticals of Bellevue, Washington, is already raising money to try the therapy commercially against HIV and other viruses such as measles and hepatitis C. ... Further reading: "Lethal mutagenesis of HIV with mutagenic nucleoside analogs" by Lawrence Loeb and others, Proceedings of the National Academy of Sciences, vol 96, p 1492 (1999) "Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs" by Lawrence Loeb and James Mullins, ...
View Blog: (BLOG) - Lifestyle in Judo - http://judo2009-blog.blogspot.com/

---

View Post: World Hepatitis Alliance calls for greater awareness to stop the ...
24 Jun 2009 by kristovsky  
Discovered at Bristol-Myers Squibb, BARACLUDE is a nucleoside analogue indicated for use in adults with chronic hepatitis B infection with compensated liver disease, evidence of active viral replication, and either evidence of ...
View Blog: News - http://moscow.fleishmanhillard.com/blogs/pov/default.aspx

---

View Post: Order rebetol
Drugs Bin
19 Oct 2009 by admin   ...
View Blog: http://drugsbin.com/

---